Noho Labs
Dynamic lymphedema reduction device
About
Noho Labs, founded in 2025, develops a wearable medical device that dynamically reduces lymphedema for patients at any time. The company targets individuals suffering from lymphedema with a non-invasive, user-controlled solution that improves quality of life. Funded initially by CEO-provided interim financing and a pre-seed round totaling $16M, Noho Labs aims to commercialize its innovative healthcare technology through partnerships with medical providers and direct patient channels.
Products
- Lymphedema Reduction Device
Market research & competitive positioning
Source-backed TAM / SAM / SOM sizing, displacement analysis, and an interactive peer positioning map for Noho Labs — available to members.
